Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Older patients ...
Researchers sought to determine whether adding mogamulizumab to CHOP would improve outcomes in older patients with adult T-cell leukemia/lymphoma.
The FDA has granted priority review to a new drug application (NDA) seeking the approval of sonrotoclax (BGB-11417; BeOne ...
Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda The cohort included 103 patients (63.1% female, 36.9% ...
The progression of disease after first-line treatment reduces overall survival and increases all-cause mortality in patients with mantle cell lymphoma, a Swedish study reports.
Stage 3 Hodgkin’s lymphoma either indicates lymphoma in the lymph nodes both above and below a person’s diaphragm or in the lymph nodes above the diaphragm and in the spleen. Doctors may also refer to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback